基础医学与临床 ›› 2016, Vol. 36 ›› Issue (4): 547-551.

• 短篇综述 • 上一篇    下一篇

溶瘤腺病毒抗肿瘤策略研究进展

李冲,王志平   

  1. 兰州大学
  • 收稿日期:2015-08-24 修回日期:2015-11-05 出版日期:2016-04-05 发布日期:2016-03-29
  • 通讯作者: 王志平 E-mail:erywzp@lzu.edu.cn
  • 基金资助:
    不依赖于CAR的膀胱癌特异性溶瘤腺病毒构建及基因靶向治疗研究

Advances in oncolytic adenovirus antitumor therapy

  • Received:2015-08-24 Revised:2015-11-05 Online:2016-04-05 Published:2016-03-29

摘要: 溶瘤腺病毒是一类经过基因工程改造,能够选择性地在肿瘤细胞中复制并溶解、杀伤肿瘤细胞的腺病毒,但不影响正常细胞功能。至今,已尝试多种方式提高溶瘤腺病毒的抗肿瘤活性和安全性,包括改变腺病毒转导方式,利用特异性启动子和增强子驱动治疗基因的表达以及协同放化疗、免疫治疗等。

关键词: 溶瘤腺病毒, 靶向治疗, 肿瘤

Abstract: Oncolytic adenovirus is a category of adenovirus which is reconstructed by genetic engineering. The adenovirus can infect and replicate in a selective and specifical manner until the tumor cell is destroyed, while it is harmless to normal cells during the process. A bulk of strategies, hitherto, have been attempted for improving the antitumor activity and safety of oncolytic adenovirus in treatment of cancer, including altering the way of transduction, utilizing tumor-specific promoter and enhancer control of the expression of therapeutic gene as well as combining with the radiotherapy, chemotherapy or immunotherapy for synergistic effect.

Key words: oncolytic adenovirus, target therapy, cancer